Be alert to the possibility of medication overuse headache
DOI:
https://doi.org/10.48208/HeadacheMed.2023.15Keywords:
Medication-overuse, Chronic headache, Migraine, ManagementAbstract
Affecting 1-2% of the world's population and representing up to 40% of patients in specialist headache services, medication overuse headache remains a challenge. Starting with the need to make professionals aware since basic care, through patient education and ending with adequate (and successful) management, there is still much to be done. This literature review seeks to draw attention not only to the importance of recognizing the condition, but mainly to bring out the latest in the best management of patients who suffer from pain more than 14 days a month and who still see analgesics as the only way to manage their pain.
Downloads
References
Kowacs F, Macedo DDP, Silva-Néto RP. Classificação Internacional das Cefaleias. 3 ed. Sao Paulo: OMNIFARMA LTDA; 2019. 207 p.
Tassorelli C, Jensen R, Allena M, De Icco R, Sances G, Katsarava Z, . . . Nappi G. A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia 2014; 34(9): 645-655 Doi:10.1177/0333102414521508 DOI: https://doi.org/10.1177/0333102414521508
Scher AI, Lipton RB, Stewart WF and Bigal M. Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study. Cephalalgia 2009; 30(3): 321-328 Doi:10.1111/j.1468-2982.2009.01913.x DOI: https://doi.org/10.1111/j.1468-2982.2009.01913.x
Thorlund K, Sun-Edelstein C, Druyts E, Kanters S, Ebrahim S, Bhambri R, . . . Tepper S. Risk of medication overuse headache across classes of treatments for acute migraine. The Journal of Headache and Pain 2016; 17(1): Doi:10.1186/s10194-016-0696-8 DOI: https://doi.org/10.1186/s10194-016-0696-8
Vandenbussche N, Laterza D, Lisicki M, Lloyd J, Lupi C, Tischler H, . . . Katsarava Z. Medication-overuse headache: a widely recognized entity amidst ongoing debate. The Journal of Headache and Pain 2018; 19(1): Doi:10.1186/s10194-018-0875-x DOI: https://doi.org/10.1186/s10194-018-0875-x
Schwedt TJ, Hentz JG, Sahai-Srivastava S, Murinova N, Spare NM, Treppendahl C, . . . Dodick DW. Patient-Centered Treatment of Chronic Migraine With Medication Overuse. Neurology 2022; 98(14): e1409-e1421 Doi:10.1212/wnl.0000000000200117 DOI: https://doi.org/10.1212/WNL.0000000000200117
Katsarava Z, Fritsche G, Muessig M, Diener HC and Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57(9): 1694-1698 Doi:10.1212/wnl.57.9.1694 DOI: https://doi.org/10.1212/WNL.57.9.1694
Kowacs F, Roesler CAP, Piovesan EJ, Sarmento EM, Campos HC, Maciel JA, Jr., . . . Jurno ME. Consensus of the Brazilian Headache Society on the treatment of chronic migraine. Arq Neuropsiquiatr 2019; 77(7): 509-520 Doi:10.1590/0004-282X20190078 DOI: https://doi.org/10.1590/0004-282x20190078
Vigano A, Torrieri MC, Toscano M, Puledda F, Petolicchio B, Sasso D'Elia T, . . . Di Piero V. Neurophysiological correlates of clinical improvement after greater occipital nerve (GON) block in chronic migraine: relevance for chronic migraine pathophysiology. J Headache Pain 2018; 19(1): 73 Doi:10.1186/s10194-018-0901-z DOI: https://doi.org/10.1186/s10194-018-0901-z
Carlsen LN, Munksgaard SB, Nielsen M, Engelstoft IMS, Westergaard ML, Bendtsen L and Jensen RH. Comparison of 3 Treatment Strategies for Medication Overuse Headache. JAMA Neurology 2020; 77(9): Doi:10.1001/jamaneurol.2020.1179 DOI: https://doi.org/10.1001/jamaneurol.2020.1179
Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G and Nappi G. Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. The Journal of Headache and Pain 2011; 12(4): 427-433 Doi:10.1007/s10194-011-0339-z DOI: https://doi.org/10.1007/s10194-011-0339-z
Dodick DW, Doty EG, Aurora SK, Ruff DD, Stauffer VL, Jedynak J, . . . Pearlman EM. Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine. Cephalalgia 2020; 41(3): 340-352 Doi:10.1177/0333102420966658 DOI: https://doi.org/10.1177/0333102420966658
Silberstein SD, Cohen JM, Seminerio MJ, Yang R, Ashina S and Katsarava Z. The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study. The Journal of Headache and Pain 2020; 21(1): Doi:10.1186/s10194-020-01173-8 DOI: https://doi.org/10.1186/s10194-020-01173-8
Tepper SJ, Diener H-C, Ashina M, Brandes JL, Friedman DI, Reuter U, . . . Mikol DD. Erenumab in chronic migraine with medication overuse. Neurology 2019; 92(20): e2309-e2320 Doi:10.1212/wnl.0000000000007497 DOI: https://doi.org/10.1212/WNL.0000000000007497
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Renata Gomes Londero (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
